RxDoctor Payments Data

Luis Alvarado Lopez, MD

General Practice · Saint Cloud, FLNPI 1467424143

Payments from drug & device makers

$245,285in general payments, 2019–2025

Across 37 payments — averaging $6629.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Currax Pharmaceuticals LLC$197K
  • Sanofi US Services Inc.$48K
  • Lilly USA, LLC$94
  • Galderma Laboratories, L.p.$78
  • Amarin Pharma, Inc.$51
  • Pfizer$50
  • plus $59 from 3 others

What the payments were for

  • Food & beverage$332100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$245,285 in reported general payments places this provider in the 95th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida

Medicare billing

Part B allowed, 2024
$3,138
Medicare patients
15
Services billed
34

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide72$79,999
JardianceEmpagliflozin41$31,914
MounjaroTirzepatide21$30,362
EliquisApixaban38$28,859
MyrbetriqMirabegron52$25,384
TradjentaLinagliptin25$16,960
FarxigaDapagliflozin Propanediol11$16,027
JanuviaSitagliptin Phosphate14$15,138
UbrelvyUbrogepant11$10,636
Rosuvastatin Calcium197$4,953
Lantus SolostarInsulin Glargine,hum.Rec.Anlog39$2,937
Albuterol Sulfate HfaAlbuterol Sulfate93$2,099
SynthroidLevothyroxine Sodium16$1,873
Ezetimibe22$1,807
Celecoxib37$1,782

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$15$48,87466 claims
Lilly USA, LLCMounjaro$94$30,36221 claims
PfizerEliquis$50$28,85938 claims
AstraZenecaFarxiga$32$16,02711 claims
MerckJanuvia$13$15,13814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,901 general practice providers in Florida.

Other general practice in Saint Cloud

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →